Chalasani N - Search Results

1

Pharmacotherapy for Nonalcoholic Fatty Liver Disease.

Gawrieh S, Chalasani N. Gawrieh S, et al. Among authors: chalasani n. Semin Liver Dis. 2015 Aug;35(3):338-48. doi: 10.1055/s-0035-1562951. Epub 2015 Sep 17. Semin Liver Dis. 2015. PMID: 26378648 Free PMC article. Review.

2

Treatment of Nonalcoholic Fatty Liver Disease.

Liangpunsakul S, Chalasani N. Liangpunsakul S, et al. Among authors: chalasani n. Curr Treat Options Gastroenterol. 2003 Dec;6(6):455-463. doi: 10.1007/s11938-003-0047-0. Curr Treat Options Gastroenterol. 2003. PMID: 14585234

3

Nonalcoholic fatty liver disease in individuals with severe obesity.

Haynes P, Liangpunsakul S, Chalasani N. Haynes P, et al. Among authors: chalasani n. Clin Liver Dis. 2004 Aug;8(3):535-47, viii. doi: 10.1016/j.cld.2004.04.007. Clin Liver Dis. 2004. PMID: 15331062 Review.

4

Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study.

Chalasani N, Vuppalanchi R, Raikwar NS, Deeg MA. Chalasani N, et al. J Clin Endocrinol Metab. 2006 Jun;91(6):2279-85. doi: 10.1210/jc.2006-0075. Epub 2006 Apr 4. J Clin Endocrinol Metab. 2006. PMID: 16595594

5

Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease.

Charlton M, Angulo P, Chalasani N, Merriman R, Viker K, Charatcharoenwitthaya P, Sanderson S, Gawrieh S, Krishnan A, Lindor K. Charlton M, et al. Among authors: chalasani n. Hepatology. 2008 Feb;47(2):484-92. doi: 10.1002/hep.22063. Hepatology. 2008. PMID: 18220286 Free PMC article.

6

Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease.

Chalasani N, Wilson L, Kleiner DE, Cummings OW, Brunt EM, Unalp A; NASH Clinical Research Network. Chalasani N, et al. J Hepatol. 2008 May;48(5):829-34. doi: 10.1016/j.jhep.2008.01.016. Epub 2008 Feb 12. J Hepatol. 2008. PMID: 18321606 Free PMC article.

7

Nonalcoholic fatty liver disease as a component of the metabolic syndrome.

Khashab MA, Liangpunsakul S, Chalasani N. Khashab MA, et al. Among authors: chalasani n. Curr Gastroenterol Rep. 2008 Feb;10(1):73-80. doi: 10.1007/s11894-008-0012-0. Curr Gastroenterol Rep. 2008. PMID: 18417046 Review.

8

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management.

Vuppalanchi R, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. Hepatology. 2009 Jan;49(1):306-17. doi: 10.1002/hep.22603. Hepatology. 2009. PMID: 19065650 Free PMC article. Review.

9

Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.

Vuppalanchi R, Unalp A, Van Natta ML, Cummings OW, Sandrasegaran KE, Hameed T, Tonascia J, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. Clin Gastroenterol Hepatol. 2009 Apr;7(4):481-6. doi: 10.1016/j.cgh.2008.12.015. Epub 2008 Dec 25. Clin Gastroenterol Hepatol. 2009. PMID: 19162235 Free PMC article.

10

Nonalcoholic fatty liver disease and cardiovascular risk.

Misra VL, Khashab M, Chalasani N. Misra VL, et al. Among authors: chalasani n. Curr Gastroenterol Rep. 2009 Feb;11(1):50-5. doi: 10.1007/s11894-009-0008-4. Curr Gastroenterol Rep. 2009. PMID: 19166659 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

562 results

Search Page